Description

Tlacott et al divided patients with cancer, fever and neutropenia into 4 prognostic groups based on clinical findings at presentation. This can help separate patients who require more aggressive management from those that have a good prognosis. The authors are from Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School in Boston.


 

Patient selection: solid or hematologic (leukemia, lymphoma) cancer

 

Criteria: fever (oral temperature >= 38.0°C) and neutropenia (absolute neutrophil count < 500 per µL)

 

Patient groups:

(1) inpatient at onset of fever and neutropenia

(2) outpatient with significant comorbidity requiring hospital admission

(3) outpatient with uncontrolled cancer

(4) outpatient without significant comorbidity or uncontrolled cancer

 

Significant comorbidities included:

(1) hypotension

(2) altered mental status

(3) respiratory failure

(4) herpes zoster

(5) clinical bleeding with severe thrombocytopenia or severe anemia

(6) deep vein thrombosis

(7) carcinomatous meningitis

(8) spontaneous pneumothorax

(9) spinal cord compression

(10) gross hematuria with urinary tract obstruction

(11) severe hypertension

(12) cavitary lung nodule

(13) presyncope

(14) dehydration and/or pain

(15) decubital ulcer

Group

Major Complications

Mortality

1

35%

16%

2

47%

16%

3

31%

13%

4

2%

0%

 

Major complications included:

(1) severe hypotension

(2) respiratory failure

(3) cardiac dysrhythmia or ECG change

(4) altered mental status

(5) focal neurologic abnormality lasting >= 24 hours

(6) congestive heart failure

(7) hemorrhage requiring transfusion with multiple units of blood

(8) severe abdominal pain

(9) aseptic meningitis

(10) lung lobe collapse

(11) veno-occlusive disease

(12) airway obstruction

(13) cardiac tamponade

(14) typhilitis

(15) opportunistic fungal infection

(16) sepsis

(17) DIC

 


To read more or access our algorithms and calculators, please log in or register.